GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

Market Cap	1.49B -23.5%
Revenue (ttm)	663.87M +16.6%
Net Income	15.70M
EPS	0.38
Shares Out	41.46M
PE Ratio	94.80
Forward PE	n/a
Dividend	0.70 (1.95%)
Ex-Dividend Date	n/a

Volume	21,121
Open	35.90
Previous Close	35.90
Day's Range	35.90 - 36.05
52-Week Range	33.65 - 67.10
Beta	0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About GeneFerm Biotechnology

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company provides microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as we...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 144
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1796